Erratum: Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation (American Journal of Transplantation 14 (2713-2722) DOI: 10.1111/ajt.12918);Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation

American Journal of Transplantation

Volumn 14, Issue 12, 2014, Pages 2713-2722

  Tena, A ^a   Kurtz, J ^a,b   Leonard, D A ^a   Dobrinsky, J R ^c   Terlouw, S L ^c   Mtango, N ^c   Verstegen, J ^c   Germana, S ^a   Mallard, C ^a   Arn, J S ^a   Sachs, D H ^a   Hawley, R J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b EMMANUEL COLLEGE   (United States)

^c Minitube of America   (United States)

Author keywords

Animal models: nonhuman primate; animal models: porcine; basic (laboratory) research science; immunosuppression immune modulation; tolerance: chimerism; xenotransplantation

Indexed keywords

CD47 ANTIGEN; CD47 PROTEIN, HUMAN; GALACTOSYLTRANSFERASE; N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW PROGENITOR CELL; CELL CLONING; CHIMERA; CONTROLLED STUDY; EMBRYO; ENGRAFTMENT; EXON; FETUS; FIBROBLAST; GRAY MATTER; HEART MUSCLE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MACROPHAGE; MINIPIG; NONHUMAN; OOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; TRANSGENIC PIG; ANIMAL; BONE MARROW; GENE INACTIVATION; GENETICS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PHAGOCYTOSIS; PHYSIOLOGY; PIG; SCID MOUSE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD47; BONE MARROW; CHIMERISM; GALACTOSYLTRANSFERASES; GENE KNOCKOUT TECHNIQUES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, SCID; PHAGOCYTOSIS; SWINE; SWINE, MINIATURE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84910647841     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13123     Document Type: Erratum

References (49)

1. Yamada K, Scalea J., Current progress in xenogeneic tolerance. Curr Opin Organ Transplant 2012; 17: 168-173.
2. Yamada K, Sachs DH, DerSimonian H., Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155: 5249-5256.
3. Murray AG, Khodadoust MM, Pober JS, Bothwell AL., Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57-63.
4. Fryer JP, Leventhal JR, Dalmasso AP, et al. Beyond hyperacute rejection: Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 1995; 59: 171-176.
5. Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW., Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059-1066.
6. Sharabi Y, Sachs DH., Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493-502.
7. Ildstad ST, Sachs DH., Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168-170.
8. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DMJ, Sachs DH., Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173-181.
9. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB., Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 1997; 64: 709-716.
10. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262.
11. Kawai T, Poncelet A, Sachs DH, et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999; 68: 1767-1775.
12. Kawai T, Sogawa H, Boskovic S, et al. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004; 4: 1391-1398.
13. Sharabi Y, Aksentijevich I, Sundt TM III, Sachs DH, Sykes M., Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195-202.
14. Bartholomew AM, Powelson J, Sachs DH, et al. Tolerance in a concordant nonhuman primate model. Transplantation 1999; 68: 1708-1716.
15. Locascio SA, Morokata T, Chittenden M, et al. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation 2010; 90: 1607-1615.
16. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
17. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4: 124ra28.
18. Tseng YL, Dor FJ, Kuwaki K, et al. Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation 2004; 11: 361-370.
19. Ide K, Ohdan H, Kobayashi T, Hara H, Ishiyama K, Asahara T., Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation 2005; 12: 181-188.
20. Basker M, Alwayn IP, Buhler L, et al. Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons. Transplantation 2001; 72: 1278-1285.
21. Buhler L, Alwayn IP, Basker M, et al. CD40-CD154 pathway blockade requires host macrophages to induce humoral unresponsiveness to pig hematopoietic cells in baboons. Transplantation 2001; 72: 1759-1768.
22. Oldenborg PA., CD47: A cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease. ISRN Hematol 2013; 2013: 614619.
23. Barclay AN, van den Berg TK., The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: Structure, function, and therapeutic target. Annu Rev Immunol 2014; 32: 25-50.
24. Oldenborg P-A, Zheleznyak A, Fang Y-F, Lagenaur CF, Gresham HD, Lindberg FP., Role of CD47 as a marker of self on red blood cells. Science 2000; 288: 2051-2054.
25. Burger P, Hilarius-Stokman P, de Korte D, van den Berg TK, van Bruggen R., CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 2012; 119: 5512-5521.
26. Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009; 138: 271-285.
27. Subramanian S, Parthasarathy R, Sen S, Boder ET, Discher DE., Species- and cell type-specific interactions between CD47 and human SIRPalpha. Blood 2006; 107: 2548-2556.
28. Subramanian S, Boder ET, Discher DE., Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site. J Biol Chem 2007; 282: 1805-1818.
29. Wang H, VerHalen J, Madariaga ML, et al. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood 2007; 109: 836-842.
30. Ide K, Wang H, Tahara H, et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007; 104: 5062-5066.
31. Wang C, Wang H, Ide K, et al. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPalpha capable of binding to human CD47. Cell Transplant 2011; 20: 1915-1920.
32. Kolber-Simonds D, Lai L, Watt SR, et al. Production of α-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 101: 7335-7340.
33. Lan P, Wang L, Diouf B, et al. Induction of human T cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism. Blood 2004; 103: 3964-3969.
34. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
35. Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters MG, Brown EJ., In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci 1995; 108: 3419-3425.
36. Rodriguez-Osorio N, Wang Z, Kasinathan P, Page GP, Robl JM, Memili E., Transcriptional reprogramming of gene expression in bovine somatic cell chromatin transfer embryos. BMC Genomics 2009; 10: 190.
37. Leonard DA, Kurtz JM, Mallard C, et al. Vascularized composite allograft tolerance across MHC barriers in a large animal model. Am J Transplant 2014; 14: 343-355.
38. Le Guern AC, Giovino MA, Abe M, et al. Stem cell activity of porcine c-kit+ hematopoietic cells. Exp Hematol 2003; 31: 833-840.
39. Zhao Y, Swenson K, Sergio JJ, Arn JS, Sachs DH, Sykes M., Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 1996; 2: 1211-1216.
40. Unkeless JC., Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580-596.
41. Lepus CM, Gibson TF, Gerber SA, et al. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. Hum Immunol 2009; 70: 790-802.
42. Yamauchi T, Takenaka K, Urata S, et al. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood 2013; 121: 1316-1325.
43. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005; 106: 1565-1573.
44. Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174: 6477-6489.
45. Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ., Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996; 274: 795-798.
46. Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A., Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 2007; 178: 5930-5939.
47. Rogers NM, Thomson AW, Isenberg JS., Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury. J Am Soc Nephrol 2012; 23: 1538-1550.
48. Soto-Pantoja DR, Ridnour LA, Wink DA, Roberts DD., Blockade of CD47 increases survival of mice exposed to lethal total body irradiation. Sci Rep 2013; 3: 1038.
49. Wilson C, Bellen HJ, Gehring WJ., Position effects on eukaryotic gene expression. Annu Rev Cell Biol 1990; 6: 679-6714.